Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21


Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial.

Meppelink R, de Bruin EI, Bögels SM.

BMC Psychiatry. 2016 Jul 26;16:267. doi: 10.1186/s12888-016-0978-3.


Treatment Sequencing for Childhood ADHD: A Multiple-Randomization Study of Adaptive Medication and Behavioral Interventions.

Pelham WE Jr, Fabiano GA, Waxmonsky JG, Greiner AR, Gnagy EM, Pelham WE 3rd, Coxe S, Verley J, Bhatia I, Hart K, Karch K, Konijnendijk E, Tresco K, Nahum-Shani I, Murphy SA.

J Clin Child Adolesc Psychol. 2016 Jul-Aug;45(4):396-415. doi: 10.1080/15374416.2015.1105138.


Comparative Cost Analysis of Sequential, Adaptive, Behavioral, Pharmacological, and Combined Treatments for Childhood ADHD.

Page TF, Pelham WE 3rd, Fabiano GA, Greiner AR, Gnagy EM, Hart KC, Coxe S, Waxmonsky JG, Foster EM, Pelham WE Jr.

J Clin Child Adolesc Psychol. 2016 Jul-Aug;45(4):416-27. doi: 10.1080/15374416.2015.1055859.


Cost-effectiveness of extended-release methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder sub-optimally treated with immediate release methylphenidate.

van der Schans J, Kotsopoulos N, Hoekstra PJ, Hak E, Postma MJ.

PLoS One. 2015 May 29;10(5):e0127237. doi: 10.1371/journal.pone.0127237.


ADHD, Multimodal Treatment, and Longitudinal Outcome: Evidence, Paradox, and Challenge.

Hinshaw SP, Arnold LE; For the MTA Cooperative Group..

Wiley Interdiscip Rev Cogn Sci. 2015 Jan;6(1):39-52.


The Estimated Annual Cost of ADHD to the U.S. Education System.

Robb JA, Sibley MH, Pelham WE Jr, Foster EM, Molina BS, Gnagy EM, Kuriyan AB.

School Ment Health. 2011 Sep 1;3(3):169-177.


Prevalence of attention-deficit/hyperactivity disorder among children with vision impairment.

DeCarlo DK, Bowman E, Monroe C, Kline R, McGwin G Jr, Owsley C.

J AAPOS. 2014 Feb;18(1):10-4. doi: 10.1016/j.jaapos.2013.10.013.


Feasibility and efficacy of yoga as an add-on intervention in attention deficit-hyperactivity disorder: An exploratory study.

Hariprasad VR, Arasappa R, Varambally S, Srinath S, Gangadhar BN.

Indian J Psychiatry. 2013 Jul;55(Suppl 3):S379-84. doi: 10.4103/0019-5545.116317.


Outcome domains in child mental health research since 1996: have they changed and why does it matter?

Hoagwood KE, Jensen PS, Acri MC, Serene Olin S, Eric Lewandowski R, Herman RJ.

J Am Acad Child Adolesc Psychiatry. 2012 Dec;51(12):1241-1260.e2. doi: 10.1016/j.jaac.2012.09.004. Review.


Children, ADHD, and citizenship.

Cohen EF, Morley CP.

J Med Philos. 2009 Apr;34(2):155-80. doi: 10.1093/jmp/jhp013. Review.


Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four years.

Wehmeier PM, Schacht A, Rothenberger A.

Child Adolesc Psychiatry Ment Health. 2009 Jan 28;3(1):3. doi: 10.1186/1753-2000-3-3.


Recent developments and strategies in pediatric pharmacology research in the USA.

Vitiello B.

Child Adolesc Psychiatry Ment Health. 2008 Dec 8;2(1):36. doi: 10.1186/1753-2000-2-36.


Once-daily treatment of ADHD with guanfacine: patient implications.

Strange BC.

Neuropsychiatr Dis Treat. 2008 Jun;4(3):499-506.


The NICE ADHD health technology assessment: a review and critique.

Schlander M.

Child Adolesc Psychiatry Ment Health. 2008 Jan 15;2(1):1. doi: 10.1186/1753-2000-2-1.


Measuring time costs in interventions designed to reduce behavior problems among children and youth.

Foster EM, Johnson-Shelton D, Taylor TK.

Am J Community Psychol. 2007 Sep;40(1-2):64-81.


Treatment for ADHD: is more complex treatment cost-effective for more complex cases?

Foster EM, Jensen PS, Schlander M, Pelham WE Jr, Hechtman L, Arnold LE, Swanson JM, Wigal T.

Health Serv Res. 2007 Feb;42(1 Pt 1):165-82.

Supplemental Content

Support Center